Back to top

$60,000,000 C&D Technologies, Inc. 5.25% Convertible Senior Notes due 2025 PURCHASE AGREEMENT

Note Purchase Agreement

$60,000,000

                             C&D Technologies, Inc.

                     5.25% Convertible Senior Notes due 2025

                               PURCHASE AGREEMENT | Document Parties: C&D TECHNOLOGIES INC | Credit Suisse First Boston LLC | Wachovia Capital Markets, LLC You are currently viewing:
This Note Purchase Agreement involves

C&D TECHNOLOGIES INC | Credit Suisse First Boston LLC | Wachovia Capital Markets, LLC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: $60,000,000 C&D Technologies, Inc. 5.25% Convertible Senior Notes due 2025 PURCHASE AGREEMENT
Governing Law: New York     Date: 4/10/2006
Industry: Electronic Instr. and Controls    

$60,000,000

                             C&D Technologies, Inc.

                     5.25% Convertible Senior Notes due 2025

                               PURCHASE AGREEMENT, Parties: c&d technologies inc , credit suisse first boston llc , wachovia capital markets  llc
50 of the Top 250 law firms use our Products every day

                                                                     Exhibit 4.2

                                   $60,000,000

                             C&D Technologies, Inc.

                     5.25% Convertible Senior Notes due 2025

                                PURCHASE AGREEMENT

                                                               November 16, 2005

Credit Suisse First Boston LLC
Wachovia Capital Markets, LLC
    c/o Credit Suisse First Boston LLC
    Eleven Madison Avenue
    New York, N.Y. 10010-3629

Dear Sirs:

            1. Introductory. C&D Technologies, Inc., a Delaware corporation (the
"Company"), proposes, subject to the terms and conditions stated herein, to
issue and sell to the several initial purchasers named in Schedule A hereto (the
"Purchasers") U.S.$60,000,000 principal amount of its 5.25% Convertible Senior
Notes due 2025 (the "Firm Securities") which are convertible into cash or a
combination of cash and shares of common stock, $0.01 par value, of the Company
(the "Underlying Shares") and, at the election of the Purchasers, an aggregate
of up to an additional $15,000,000 principal amount ("Optional Securities") of
its 5.25% Convertible Senior Notes due 2025 (the Firm Securities and the
Optional Securities which the Purchasers may elect to purchase pursuant to
Section 3 hereof are herein collectively called the "Offered Securities") each
to be issued under an indenture to be dated as of November 21, 2005 (the
"Indenture"), between the Company and The Bank of New York, as Trustee, on a
private placement basis pursuant to an exemption under Section 4(2) of the
United States Securities Act of 1933, as amended (the "Securities Act"), and
hereby agrees with the several Purchasers as follows:

            The Offered Securities will be convertible into shares of common
stock, par value $0.01 per share, of the Company (the "Common Stock ") in
accordance with the terms of the Offered Securities and the Indenture, at the
initial conversion rate specified in Schedule B hereto.

            The holders of the Offered Securities will be entitled to the
benefits of a Registration Rights Agreement to be dated as of November 21, 2005
among the Company and the Purchasers (the "Registration Rights Agreement"),
pursuant to which the Company agrees to file a registration statement with the
Securities and Exchange Commission (the "Commission") registering the resale of
the Offered Securities and the Underlying Shares under the Securities Act.

            2. Representations and Warranties of the Company. The Company
represents and warrants to, and agrees with, the several Purchasers that:

            (a) A preliminary offering circular and an offering circular
relating to the Offered Securities have been prepared by the Company. Such
preliminary offering circular (the "Preliminary Offering Circular") and offering
circular (the "Offering Circular"), as amended or supplemented as of the date of
this Agreement, together with any other document approved by the Company for use
in con-

<PAGE>

nection with the contemplated resale of the Offered Securities, are hereinafter
collectively referred to as the "Offering Document". On the date of this
Agreement, the Offering Document does not, and as of the Closing Date will not,
include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The preceding sentence
does not apply to statements in or omissions from the Offering Document based
upon written information furnished to the Company by any Purchaser through
Credit Suisse First Boston LLC ("CSFB") specifically for use therein, it being
understood and agreed that the only such information is that described as such
in Section 7(b) hereof. Except as disclosed in the Offering Document, the
Company's Annual Report on Form 10-K most recently filed with the Commission and
all subsequent reports (collectively, the "Exchange Act Reports") which have
been filed by the Company with the Commission or sent to stockholders pursuant
to the Securities Exchange Act of 1934, as amended (the "Exchange Act") did not,
as of their respective filing dates, include any untrue statement of a material
fact or omit to state any material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading. Such documents, when they were filed with the Commission, conformed
in all material respects to the requirements of the Exchange Act and the rules
and regulations of the Commission thereunder. For purposes of this Agreement,
the phrases "disclosed in the Offering Document" or "contained in the
Preliminary Offering Circular," or words of similar import, shall refer to the
disclosure contained in the Offering Document as if the information incorporated
therein by reference from the Exchange Act Reports were set forth in full
therein.

            (b) The Offered Securities have been duly authorized by the Company
and, when delivered and paid for pursuant to this Agreement and the Indenture,
will have been duly executed, authenticated, issued and delivered and will
constitute valid and legally binding obligations of the Company, entitled to the
benefits provided in the Indenture and enforceable in accordance with their
terms, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors' rights
generally or by equitable principles relating to enforceability.

             (c) The Company has submitted an application for listing the
Underlying Shares with the New York Stock Exchange ("NYSE").

            (d) The Company has been duly incorporated and is an existing
corporation in good standing under the laws of the State of Delaware, with power
and authority (corporate and other) to own its properties and conduct its
business as described in the Offering Document; and the Company is duly
qualified to do business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the conduct of its
business requires such qualification.

            (e) Each subsidiary of the Company has been duly incorporated or
organized and is an existing corporation or other entity in good standing under
the laws of the jurisdiction of its incorporation or organization, with power
and authority (corporate and other) to own its properties and conduct its
business as described in the Offering Document; and each subsidiary of the
Company is duly qualified to do business as a foreign corporation or other
entity in good standing in all other jurisdictions in which its ownership or
lease of property or the conduct of its business requires such qualification;
all of the issued and outstanding capital stock of each subsidiary of the
Company has been duly authorized and validly issued and is fully paid and
nonassessable; and the capital stock of each subsidiary owned by the Company,
directly or through subsidiaries, is owned free from liens, encumbrances and
defects. The subsidiaries listed in Schedule B to this Agreement are the only
subsidiaries of the Company.

            (f) The Company has a capitalization as set forth in the Offering
Document under the heading "Capitalization".


                                       -2-
<PAGE>

            (g) The Indenture has been duly authorized by the Company and, when
duly executed and delivered in accordance with its terms by each of the parties
thereto on the First Closing Date, will constitute a valid and legally binding
agreement of the Company enforceable against the Company in accordance with its
terms, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors' rights
generally or by equitable principles relating to enforceability; and on the
First Closing Date (as defined in Section 3 hereof), the Indenture will conform
in all material respects to the requirements of the Trust Indenture Act of 1939,
as amended (the "Trust Indenture Act "), and the rules and regulations of the
Commission applicable to an indenture that is qualified thereunder;

            (h) When the Offered Securities are delivered and paid for pursuant
to this Agreement on the Closing Date, such Offered Securities will be
convertible into shares of Common Stock of the Company in accordance with the
terms of the Indenture; the Underlying Shares initially issuable upon conversion
of such Offered Securities have been duly authorized and reserved for issuance
upon such conversion and, when issued upon such conversion, will be validly
issued, fully paid and nonassessable; the outstanding Underlying Shares have
been duly authorized and validly issued, are fully paid and nonassessable and
conform to the description thereof contained in the Offering Document; and the
stockholders of the Company have no preemptive rights with respect to the
Offered Securities or the Underlying Shares.

            (i) Except as disclosed in the Offering Document, there are no
contracts, agreements or understandings between the Company and any person that
would give rise to a valid claim against the Company or any Purchaser for a
brokerage commission, finder's fee or other like payment with respect to the
offer and sale of the Offered Securities.

            (j) No consent, approval, authorization, or order of, or filing
with, any governmental agency or body or any court is required for the
consummation of the transactions contemplated by this Agreement and the
Registration Rights Agreement in connection with the issuance and sale of the
Offered Securities by the Company, except for the filing with the Commission of
the Shelf Registration Statement (as defined in the Registration Rights
Agreement) and the order of the Commission declaring the Shelf Registration
Statement effective.

            (k) The execution, delivery and performance of the Indenture, this
Agreement and the Registration Rights Agreement, and the issuance and sale of
the Offered Securities and compliance with the terms and provisions thereof will
not result in a breach or violation of any of the terms and provisions of, or
constitute a default under (i) any statute, rule, regulation or order of any
governmental agency or body or any court, domestic or foreign, having
jurisdiction over the Company or any subsidiary of the Company or any of their
properties, (ii) any agreement or instrument to which the Company or any such
subsidiary is a party or by which the Company or any such subsidiary is bound or
to which any of the properties of the Company or any such subsidiary is subject,
or (iii) the charter or by-laws of the Company or any such subsidiary, in each
case, that would reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect, and the Company has full power and authority to
authorize, issue and sell the Offered Securities as contemplated by this
Agreement.

            (l) This Agreement has been duly authorized, executed and delivered
by the Company.

            (m) The Registration Rights Agreement has been duly authorized by
the Company and, when duly executed and delivered in accordance with its terms
by each of the parties thereto on the First Closing Date, will constitute a
valid and legally binding agreement of the Company enforceable against the
Company in accordance with its terms, except as enforceability may be limited by
applicable


                                      -3-
<PAGE>

bankruptcy, insolvency or similar laws affecting the enforcement of creditors'
rights generally or by equitable principles relating to enforceability, and
except that rights to indemnity and contribution thereunder may be limited by
applicable law and public policy.

            (n) Except as disclosed in the Offering Document, neither the
Company nor any of its subsidiaries is (i) in violation of its charter, by-laws
or similar organizational documents; (ii) in default, and no event has occurred
that, with notice or lapse of time or both, would constitute such a default, in
the due performance or observance of any term, covenant or condition contained
in any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which the Company or any of its subsidiaries is a party or by
which the Company or any of its subsidiaries is bound or to which any of the
property or assets of the Company or any of its subsidiaries is subject; or
(iii) in violation of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory authority,
except, in the case of clauses (ii) and (iii) above, for any such default or
violation that would not, individually or in the aggregate, reasonably be
expected to have a material adverse effect on the condition (financial or
other), business, properties or results of operations of the Company and its
subsidiaries taken as a whole ("Material Adverse Effect").

            (o) Except as disclosed in the Offering Document, the Company and
its subsidiaries have good and marketable title to all real properties and all
other properties and assets owned by them, in each case free from liens,
encumbrances and defects that would materially affect the value thereof or
materially interfere with the use made or to be made thereof by them; and except
as disclosed in the Offering Document, the Company and its subsidiaries hold any
leased real or personal property under valid and enforceable leases with no
exceptions that would materially interfere with the use made or to be made
thereof by them.

            (p) The Company and its subsidiaries possess adequate certificates,
authorities or permits issued by appropriate governmental agencies or bodies
necessary to conduct the business now operated by them and have not received any
notice of proceedings relating to the revocation or modification of any such
certificate, authority or permit that, if determined adversely to the Company or
any of its subsidiaries, would individually or in the aggregate reasonably be
expected to have a Material Adverse Effect.

            (q) No labor dispute with the employees of the Company or any
subsidiary exists or, to the knowledge of the Company, is imminent that would
reasonably be expected to have a Material Adverse Effect.

            (r) The Company and its subsidiaries own, possess or can acquire on
reasonable terms, adequate trademarks, trade names and other rights to
inventions, know-how, patents, copyrights, confidential information and other
intellectual property (collectively, "intellectual property rights") necessary
to conduct the business now operated by them, or presently employed by them, and
have not received any notice of infringement of or conflict with asserted rights
of others with respect to any intellectual property rights that, if determined
adversely to the Company or any of its subsidiaries, would individually or in
the aggregate reasonably be expected to have a Material Adverse Effect.

            (s) Except as disclosed in the Offering Document, neither the
Company nor any of its subsidiaries is in violation of any statute, rule,
regulation, decision or order of any governmental agency or body or any court,
domestic or foreign, relating to the use, disposal or release of hazardous or
toxic substances or relating to the protection or restoration of the environment
or human exposure to hazardous or toxic substances (collectively, "environmental
laws"), owns or operates any real property contaminated with any substance that
is subject to any environmental laws, is liable for any off-site disposal or
contamination pursuant to any environmental laws, or is subject to any claim
relating to any environ-


                                      -4-
<PAGE>

mental laws, which violation, contamination, liability or claim would
individually or in the aggregate reasonably be expected to have a Material
Adverse Effect; and the Company is not aware of any pending investigation which
would reasonably be expected to lead to such a claim.

            (t) Except as disclosed in the Offering Document, there are no
pending actions, suits or proceedings against or affecting the Company, any of
its subsidiaries or any of their respective properties that, if determined
adversely to the Company or any of its subsidiaries, would individually or in
the aggregate reasonably be expected to have a Material Adverse Effect, or would
materially and adversely affect the ability of the Company to perform its
obligations under the Indenture, this Agreement or the Registration Rights
Agreement, or which are otherwise material in the context of the sale of the
Offered Securities; and no such actions, suits or proceedings are threatened or,
to the Company's knowledge, contemplated; and (i) there are no current or
pending legal, governmental or regulatory actions, suits or proceedings that
would be required under the Securities Act to be described in a prospectus that
are not so described in the Offering Document and (ii) there are no contracts or
other documents that are required under the Securities Act to be filed as
exhibits to a registration statement or described in a registration statement or
a prospectus that are not filed with the Commission or described in the Offering
Document.

            (u) The financial statements included in the Offering Document
present fairly the financial position of the Company and its consolidated
subsidiaries as of the dates shown and their results of operations and cash
flows for the periods shown, and such financial statements have been prepared in
conformity with the generally accepted accounting principles in the United
States applied on a consistent basis except as may be stated in the notes
thereto.

            (v) Except as disclosed in the Offering Document, since the date of
the latest audited financial statements included in the Offering Document, there
has been no material adverse change, nor any development or event involving a
prospective material adverse change, in the condition (financial or other),
business, properties or results of operations of the Company and its
subsidiaries taken as a whole, and, except as disclosed in or contemplated by
the Offering Document, there has been no dividend or distribution of any kind
declared, paid or made by the Company on any class of its capital stock.

            (w) The Company is subject to the reporting requirements of either
Section 13 or Section 15(d) of the Exchange Act and files reports with the
Commission on the Electronic Data Gathering, Analysis, and Retrieval (EDGAR)
system.

            (x) Each employee benefit plan, within the meaning of Section 3(3)
of the Employee Retirement Income Security Act of 1974, as amended ("ERISA "),
that is maintained, administered or contributed to by the Company or any of its
affiliates for employees or former employees of the Company and its affiliates
has been maintained in all material respects in compliance with its terms and
the requirements of any applicable statutes, orders, rules and regulations,
including but not limited to ERISA and the Internal Revenue Code of 1986, as
amended (the "Code"); no prohibited transaction, within the meaning of Section
406 of ERISA or Section 4975 of the Code, has occurred with respect to any such
plan excluding transactions effected pursuant to a statutory or administrative
exemption; and for each such plan that is subject to the funding rules of
Section 412 of the Code or Section 302 of ERISA, no "accumulated funding
deficiency" as defined in Section 412 of the Code has been incurred, whether or
not waived, and the fair market value of the assets of each such plan (excluding
for these purposes accrued but unpaid contributions) exceeds the present value
of all benefits accrued under such plan determined using reasonable actuarial
assumptions.

            (y) Each of the Company and its subsidiaries has filed all necessary
federal, state and foreign income and franchise tax returns, except where the
failure to so file such returns would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, and has paid all


                                      -5-
<PAGE>

taxes shown as due thereon; and other than tax deficiencies which the Company or
any subsidiary, as the case may be, are contesting in good faith and for which
the Company or such subsidiary, as the case may be, has provided adequate
reserves, there is no tax deficiency that has been asserted against the Company
or any of the subsidiaries that would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.

            (z) The Company and its subsidiaries maintain systems of internal
accounting controls sufficient to provide reasonable assurance that in all
material respects (i) transactions are executed in accordance with management's
general or specific authorizations; (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally
accepted accounting principles and to maintain asset accountability; (iii)
access to assets is permitted only in accordance with management's general or
specific authorization; and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.

            (aa) The Company and its subsidiaries have insurance covering their
respective properties, operations, personnel and businesses, which insurance is
in amounts and insures against such losses and risks as are reasonably adequate
for the conduct by the Company and its subsidiaries of their respective
businesses.

            (bb) Neither the Company nor any of its subsidiaries nor, to the
Company's knowledge, any director, officer, agent, employee or other person
associated with or acting on behalf of the Company or any of its subsidiaries
has (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in
violation of any provision of the Foreign Corrupt Practices Act of 1977; or (iv)
made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment.

            (cc) On and immediately after the Closing Date, the Company (after
giving effect to the issuance of the Offered Securities and the other
transactions related thereto as described in the Offering Document) will be
Solvent. As used in this paragraph, the term "Solvent " means, with respect to a
particular date, that on such date the present fair market value (or present
fair saleable value) of the assets of the Company is not less than the total
amount required to pay the liabilities of the Company on its total existing
debts and liabilities (including contingent liabilities) as they become absolute
and matured.

            (dd) The Company is not an open-end investment company, unit
investment trust or face-amount certificate company that is or is required to be
registered under Section 8 of the United States Investment Company Act of 1940,
as amended (the "Investment Company Act"); and the Company is not and, after
giving effect to the offering and sale of the Offered Securities and the
application of the proceeds thereof as described in the Offering Document, will
not be an "investment company" as defined in the Investment Company Act.

            (ee) No securities of the same class (within the meaning of Rule
144A(d)(3) under the Securities Act) as the Offered Securities are listed on any
national securities exchange registered under Section 6 of the Exchange Act or
quoted in a U.S. automated inter-dealer quotation system; and each of the
Preliminary Offering Circular and the Offering Circular, as of its respective
date, contains or will contain all the information that, if requested by a
prospective purchaser of the Offered Securities, would be required to be
provided to such prospective purchaser pursuant to Rule 144A(d)(4) under the
Securities Act.


                                      -6-
<PAGE>

            (ff) Neither the Company nor any of its affiliates (as defined in
Rule 501(b) of Regulation D under the Securities Act) has, directly or through
any agent, sold, offered for sale, solicited offers to buy or otherwise
negotiated in respect of, any security (as defined in the Securities Act), that
is or will be integrated with the sale of the Offered Securities in a manner
that would require registration of the Offered Securities under the Securities
Act.

            (gg) The offer and sale of the Offered Securities by the Company to
the several Purchasers in the manner contemplated by this Agreement will be
exempt from the registration requirements of the Securities Act by reason of
Section 4(2) thereof, Regulation D thereunder and Regulation S; and it is not
necessary to qualify an indenture in respect of the Offered Securities under the
Trust Indenture Act.

            (hh) Neither the Company, nor any of its affiliates, nor any person
acting on its or their behalf (i) has, within the six-month period prior to the
date hereof, offered or sold in the United States or to any U.S. person (as such
terms are defined in Regulation S under the Securities Act) the Offered
Securities or any security of the same class or series as the Offered Securities
or (ii) has offered or will offer or sell the Offered Securities (A) in the
United States by means of any form of general solicitation or general
advertising within the meaning of Rule 502(c) under the Securities Act or (B)
with respect to any securities sold in reliance on Rule 903 of Regulation S, by
means of any directed selling efforts within the meaning of Rule 902(c) of
Regulation S. The Company has not entered and will not enter into any
contractual arrangement with respect to the distribution of the Offered
Securities except for this Agreement and any engagement agreement with a
Purchaser.

            (ii) Nothing has come to the attention of the Company that has
caused the Company to believe that the statistical and market-related data
included in the Offering Document is not based on or derived from sources that
are reliable and accurate in all material respects.

            (jj) No relationship, direct or indirect, exists between or among
the Company or any of its subsidiaries, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company or any of its
subsidiaries, on the other, that is required by the Securities Act to be
described in a prospectus that is not so described in the Offering Document.

            (kk) There is and has been no failure on the part of the Company or
any of the Company's directors or officers, in their capacities as such, to
comply in all material respects with any provision of the Sarbanes-Oxley Act of
2002 and the rules and regulations promulgated in connection therewith (the
"Sarbanes-Oxley Act"), including Section 402 related to loans and Sections 302
and 906 related to certifications.

            (ll) The proceeds to the Company from the offering of the Offered
Securities will not be used to purchase or carry any security.

            3. Purchase, Sale and Delivery of Offered Securities. On the basis
of the representations, warranties and agreements herein contained, but subject
to the terms and conditions herein set forth, the Company agrees to sell to the
Purchasers, and the Purchasers agree, severally and not jointly, to purchase
from the Company, at a purchase price of 97.0% of the principal amount thereof
plus accrued interest from November 21, 2005 to the First Closing Date (as
hereinafter defined), the respective principal amounts of Firm Securities set
forth opposite the names of the several Purchasers in Schedule A hereto.

            The Company will deliver against payment of the purchase price the
Firm Securities in the form of one or more permanent global securities in
definitive form (the "Firm Global Securities") deposited with the Trustee as
custodian for The Depository Trust Company ("DTC") and registered in the


                                      -7-
<PAGE>

name of Cede & Co., as nominee for DTC. Interests in any permanent global
securities will be held only in book-entry form through DTC, except in the
limited circumstances described in the Offering Document. Payment for the Firm
Securities shall be made by the Purchasers in Federal (same day) funds by
official check or checks or wire transfer to an account at a bank acceptable to
CSFB at the office of Cahill Gordon & Reindel LLP at 9:00 A.M. (New York time),
on November 21, 2005, or at such other time not later than seven full business
days thereafter as CSFB and the Company determine, such time being herein
referred to as the "First Closing Date", against delivery to the Trustee as
custodian for DTC of the Firm Global Securities representing all of the Firm
Securities. The Firm Global Securities will be made available for checking at
the offices of Cahill Gordon & Reindel LLP at least 24 hours prior to the First
Closing Date.

            In addition, upon written notice from CSFB given to the Company from
time to time not more than 30 days subsequent to the date of this Agreement, the
Purchasers may purchase all or less than all of the Optional Securities at the
purchase price of 97.0% of the principal amount of Optional Securities
(including any accrued interest thereon from November 21, 2005 to the related
Optional Closing Date (as defined below)). The Company agrees to sell to the
Purchasers the principal amount of Optional Securities specified in such notice
and the Purchasers agree, severally and not jointly, to purchase such Optional
Securities. Such Optional Securities shall be purchased from the Company for the
account of each Purchaser in the same proportion as the principal amount of Firm
Securities set forth opposite such Purchaser's name in Schedule A hereto bears
to the total principal amount of Firm Securities (subject to adjustment by CSFB
to eliminate fractions). No Optional Securities shall be sold or delivered
unless the Firm Securities previously have been, or simultaneously are, sold and
delivered. The right to purchase the Optional Securities or any portion thereof
may be exercised from time to time and to the extent not previously exercised
may be surrendered and terminated at any time upon notice by CSFB to the
Company.

            Each time for the delivery of and payment for the Optional
Securities, being herein referred to as the "Optional Closing Date", which may
be the First Closing Date (the First Closing Date and each Optional Closing
Date, if any, being sometimes referred to as a "Closing Date"), shall be
determined by CSFB on behalf of the several Purchasers but shall not be later
than seven full business days after written notice of election to purchase
Optional Securities is given. The Company will deliver against payment of the
purchase price the Optional Securities being purchased on each Optional Closing
Date in the form of one or more permanent global Securities in definitive form
(each, an "Optional Global Security") deposited with the Trustee as custodian
for DTC and registered in the name of Cede & Co., as nominee for DTC. Payment
for such Optional Securities shall be made by the Purchasers in Federal (same
day) funds by official check or checks or wire transfer to an account at a bank
acceptable to CSFB at the office of Cahill Gordon & Reindel LLP, against
delivery to the Trustee as custodian for DTC of the Optional Global Securities
representing all of the Optional Securities being purchased on such Optional
Closing Date.

            4. Representations by Purchasers; Resale by Purchasers.

            (a) Each Purchaser severally represents and warrants to the Company
that it is an "accredited investor" within the meaning of Regulation D under the
Securities Act.

            (b) Each Purchaser severally acknowledges that the Offered
Securities have not been registered under the Securities Act and may not be
offered or sold within the United States or to, or for the account or benefit
of, U.S. persons except in accordance with Regulation S or pursuant to an
exemption from the registration requirements of the Securities Act. Each
Purchaser severally represents and agrees that it has offered and sold the
Offered Securities and will offer and sell the Offered Securities (i) as part of
their distribution at any time and (ii) otherwise until the later of the
commencement of the


                                      -8-
<PAGE>

offering and the latest Closing Date, only in accordance with Rule 144A ("Rule
144A") or Rule 903 under the Securities Act. Accordingly, neither such Purchaser
nor its affiliates, nor any persons acting on its or their behalf, have engaged
or will engage in any directed selling efforts with respect to the Offered
Securities, and such Purchaser, its affiliates and all persons acting on its or
their behalf have complied and will comply with the offering restrictions
requirement of Regulation S. Each Purchaser severally agrees that, at or prior
to confirmation of sale of the Offered Securities, other than a sale pursuant to
Rule 144A, such Purchaser will have sent to each distributor, dealer or person
receiving a selling concession, fee or other remuneration that purchases the
Offered Securities from it during the restricted period a confirmation or notice
to substantially the following effect:

      "The Securities covered hereby have not been registered under the U.S.
      Securities Act of 1933 (the "Securities Act") and may not be offered or
      sold within the United States or to, or for the account or benefit of,
      U.S. persons (i) as part of their distribution at any time or (ii)
      otherwise until 40 days after the later of the date of the commencement of
      the offering and the closing date, except in either case in accordance
      with Regulation S (or Rule 144A if available) under the Securities Act.
      Terms used above have the meanings given to them by Regulation S."

            Terms used in this subsection (b) have the meanings given to them by
Regulation S.

            (c) Each Purchaser severally agrees that it and each of its
affiliates has not entered and will not enter into any contractual arrangement
with respect to the distribution of the Offered Securities except for any such
arrangements with the other Purchasers or affiliates of the other Purchasers or
with the prior written consent of the Company.

             (d) Each Purchaser severally agrees that it and each of its
affiliates will not offer or sell the Offered Securities by means of any form of
general solicitation or general advertising, within the meaning of Rule 502(c)
under the Securities Act, including, but not limited to (i) any advertisement,
article, notice or other communication published in any newspaper, magazine or
similar media or broadcast over television or radio, or (ii) any seminar or
meeting whose attendees have been invited by any general solicitation or general
advertising. Each Purchaser severally agrees, with respect to resales made in
reliance on Rule 144A of any of the Offered Securities, to deliver either with
the confirmation of such resale or otherwise prior to settlement of such resale
a notice to the effect that the resale of such Offered Securities has been made
in reliance upon the exemption from the registration requirements of the
Securities Act provided by Rule 144A.

            (e) Each Purchaser severally acknowledges and agrees that the
Offered Securities and any Underlying Shares issued upon conversion thereof
shall bear the legend described in the Offering Document for the period
specified therein.

            (f) In relation to each member state (each, a "Member State") of the
European Economic Area (European Union member states plus Norway, Iceland and
Liechtenstein) that has implemented Directive 2003/71/EC, including any relevant
implementing measure in each such Member State (the "Prospectus Directive" and
each such Member State that has implemented the Prospectus Directive, a
"Relevant Member State"), each Purchaser severally agrees that with effect from
and including the date on which the Prospectus Directive is implemented in that
Relevant Member State (the "Relevant Implementation Date") it has not made and
will not make an offer of the Offered Securities to the public in that Relevant
Member State prior to the publication of a prospectus in relation to the Offered
Securities which has been approved by the competent authority in that Relevant
Member State or, where appropr


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more